Further to news last week regarding the Human Papilloma Virus vaccine causing health problems in teenage girls the Department of Health has announced that from September 2012 the vaccine used will be swapped to Gardasil.
The move is not thought to be related to the risks found with the Cervarix vaccine but is instead due to the hope that Gardasil will protect against genital warts, alongside its protection against cervicalRelating either to the cervix (the neck of the womb) or to the cervical vertebrae in the neck (cervical spine).cancerAbnormal, uncontrolled cell division resulting in a malignant tumour that may invade surrounding tissues or spread to distant parts of the body.. There are multiple types of Human Papilloma Virus (HPVAn abbreviation for human papilloma virus, a sexually transmitted virus that can cause genital warts and may also have a role in the development of various cancers.), many of which are responsible for genital warts, and two of which cause more than 70% of cervical cancer. Both vaccines protect against these two types of HPV but Gardasil is found to protect against more types than its cheaper alternative, Cervarix.
Gardasil has been the most popular HPV vaccine worldwide and it has been found that the numbers of people infected with genital warts in Australia dramatically fell with the introduction of the vaccine. The Department of Health is hoping that the vaccine will build on the 400 cervical cancer deaths prevented each year due to the vaccinations.